Get startedLog in
    Picture of PRISM Biolab Co logo

    206A — PRISM Biolab Co Income Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for PRISM Biolab Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

    2022
    September 30th
    2023
    September 30th
    2024
    September 30th
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSYuho
    Standards:
    JAS
    JAS
    JAS
    Status:FinalFinalFinal
    Revenue
    Total Revenue554113306
    Cost of Revenue
    Gross Profit53580.3161
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses4926381,305
    Operating Profit62.2-525-999
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes74.2-526-1,048
    Provision for Income Taxes
    Net Income After Taxes73-527-1,050
    Net Income Before Extraordinary Items
    Net Income73-527-1,050
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income73-527-1,050
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS2.19-14.4-25.3
    Dividends per Share
    0